scispace - formally typeset
S

Shay Soker

Researcher at Wake Forest Institute for Regenerative Medicine

Publications -  272
Citations -  26707

Shay Soker is an academic researcher from Wake Forest Institute for Regenerative Medicine. The author has contributed to research in topics: Stem cell & Vascular endothelial growth factor. The author has an hindex of 72, co-authored 257 publications receiving 24230 citations. Previous affiliations of Shay Soker include Forest Institute & Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor

TL;DR: It is proposed that neuropilin-1 is a novel V EGF receptor that modulates VEGF binding to KDR and subsequent bioactivity and therefore may regulate VEGf-induced angiogenesis.
Journal ArticleDOI

Isolation of amniotic stem cell lines with potential for therapy.

TL;DR: The isolation of human and rodent amniotic fluid–derived stem (AFS) cells that express embryonic and adult stem cell markers are reported and examples of differentiated cells derived from human AFS cells and displaying specialized functions include neuronal lineage cells secreting the neurotransmitter L-glutamate or expressing G-protein-gated inwardly rectifying potassium channels.
Journal ArticleDOI

Tissue-engineered autologous bladders for patients needing cystoplasty

TL;DR: Engineered bladder tissues, created with autologous cells seeded on collagen-polyglycolic acid scaffolds, and wrapped in omentum after implantation, can be used in patients who need cystoplasty.
Journal ArticleDOI

Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo.

TL;DR: Results indicate that EPCs can function similarly to arterial endothelial cells and thereby confer longer vascular-graft survival and might have other general applications for tissue-engineered structures and in treating vascular diseases.
Journal ArticleDOI

The use of whole organ decellularization for the generation of a vascularized liver organoid

TL;DR: Three‐dimensional, naturally derived scaffolds with an intact vascular tree are fabricated and may provide the necessary tools to produce the first fully functional bioengineered livers for organ transplantation and drug discovery.